CRISIL reaffirms credit ratings on Kopran's bank facilities; Stock rises

23 May 2022 , 12:02 PM

CRISIL Ratings has reaffirmed its ‘CRISIL BBB+/Stable/CRISIL A2’ ratings on the bank loan facilities of Kopran Limited (Kopran; part of the Kopran group).

As per the rating rationle report, the ratings continue to reflect the extensive experience of promoters in the pharmaceutical industry, and healthy financial risk profile. These strengths are partially offset by the working capital-intensive operations, and susceptibility of operating profitability to volatility in raw material prices.

Further, for arriving at its ratings, CRISIL Ratings continues to fully consolidate the business and financial risk profiles of Kopran Limited (Kopran) and its wholly-owned subsidiaries, collectively referred to as the Kopran group, as they are in the similar line of business and have significant operational and financial linkages.

At around 12:03 PM, Kopran was trading at Rs228.85 apiece up by Rs2.05 or 0.9% on the BSE.